← FDA Drug Approvals (Drugs@FDA)
SUCRALFATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AMNEAL · Approved 2019-12-02
Drug application
- FDA Application #
ANDA209356- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- SUCRALFATE
- Generic name
- SUCRALFATE ORAL
- Active ingredients
- SUCRALFATE
- Dosage form
- SUSPENSION
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- AMNEAL
- Manufacturer
- AvPAK
- First approval
- 2019-12-02
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown